Pharmacists have expressed concern over the increasing incidence of incomplete malaria treatments among patients, citing potential health risks including drug resistance and a rise in severe malaria cases.
Dr. Michael Obaro, a Consultant Clinical Pharmacologist and Malaria Scientist at the University College Hospital in Ibadan, highlighted the issue during the 43rd Annual Conference of the Association of Community Pharmacists of Nigeria at the International Conference Centre, University of Ibadan.
Dr. Obaro revealed that over 60 percent of Nigerians discontinue oral malaria medications before completing the prescribed course, presenting a significant obstacle to effective treatment. He emphasized the need to improve medication adherence and introduced Coatal Forte Soft Gelatin Capsules—a new formulation of artemether and lumefantrine—as a solution.
These soft gel capsules, which offer enhanced bioavailability and patient-friendly attributes, could play a crucial role in improving treatment adherence. Unlike traditional tablets, soft gels improve drug absorption, ensure consistent dosing, and are convenient for patients with limited access to clean water. They also feature tamper-evident packaging, enhancing safety and consumer trust.
Abimbola Bowoto from Geneith Pharmaceuticals Limited echoed these concerns, noting that adopting patient-friendly antimalarials like soft gel capsules could help mitigate issues of incomplete treatment and reduce mortality rates from malaria.
